Back to search

National and Kapodistrian University of Athens

Understanding and evaluating the performance of orally administered medicinal products in the upper and in the lower gastrointestinal lumen

Abstract

dc:description

The present thesis had three main objectives: 1.To evaluate the clinical efficacy of an antacid chewable tablet, 2.To evaluate the Biorelevant Gastrointestinal (BioGIT) system in screening for differences in early intestine under normal and reduced gastric acid secretions, 3.To evaluate the usefulness of optimized human fecal material in simulating the bacterial degradation of sulfoxides in the lower intestine.For the evaluation of the clinical efficacy of the antacid chewable tablets AA [calcium carbonate (0.500 g/tab) and magnesium oxide (0.250 g/tab), ΑΑ tablets], twelve healthy male adults were intubated with a nasogastric feeding tube and gastric contents were aspirated from the antrum of the stomach for 60 min before and 60 min after the administration of two AA tablets. The pH was measured upon aspiration. The individual pH values ranged from 1.2 to 2.7 before the administration of AA tablets. After the administration of two AA tablets gastric pH increased within 5 min for all volunteers with values ranging from 5.8 to 9.1. The time needed for the pH to return to baseline values was quite variable among the volunteers. Administration of two AA tablets significantly increases the fasting gastric pH of healthy young adults to values higher than the baseline value for a period of at least 45 min.For the evaluation of BioGIT system in screening for differences in early exposure, the impact of dose and/or formulation on early exposure after administration of disintegrating immediate release or enabling drug products of lipophilic APIs with a glass of water in the fasted state was firstly assessed. Data from BioGIT experiments using three model compounds (Compound A, Compound E and fenofibrate), formulated at various doses and/or dosage forms were evaluated based on plasma data. Mean BioGIT AUC0–50min values were useful for evaluating the impact of dose and/or formulation on early exposure after administration of products of lipophilic active pharmaceutical ingredients (APIs) to healthy fasted adults with a glass of water. The ratios of AUC values of the data collected during this study and of previously collected data were calculated for the BioGIT and the respective plasma data. The ratios were logarithmically transformed and included to a previously established correlation between log-transformed BioGIT AUC0-50min ratios and log-transformed plasma AUC0-60min in order to strengthen the observed relationship. This implementation of the data improved the characteristics of the correlation and further confirmed the usefulness of BioGIT as a screening tool for assessing the impact of dose and/or formulation on early exposure. Potential limitations of the BioGIT system in evaluating the effect of dose or formulation in the early exposure in the fasted state were also investigated using four case studies. BioGIT data can be misleading when data are highly variable, when the dose is not administered with a glass of water and/or when aqueous drug solutions are used. Finally, the rapid dissolution of nanocrystals after administration of low solubility weak bases requires adjustment of the pH in the gastric compartment of BioGIT to slightly higher pH values. These limitations identified for BioGIT system may also apply to other relevant in vitro methodologies for which relevant data are still lacking. Lastly, the usefulness of BioGIT in evaluating the impact of reduced gastric acid secretions on intraluminal concentrations was assessed using three model low solubility weakly basic compounds (indinavir sulfate, atazanavir sulfate and ritovanir). BioGIT could be effectively used as a screening tool for predicting possible effect of reduced gastric acid secretions on intraluminal concentrations of weakly basic compounds. Special caution should be given to APIs formulated as salts, as the effect of possible differences between human and simulated media composition may lead to under- (or maybe over-) estimation of the magnitude of the effect.For the evaluation of the usefulness of optimized human fecal material in simulating the bacterial degradation of sulfinpyrazone and sulindac in the lower intestine, ex vivo degradation experiments in Simulated Colonic Bacteria (SCoB) were performed under anaerobic conditions and the data were evaluated against published in vivo data. The degradation of both sulfoxides in SCoB was substantial. Sulindac, sulindac sulfide and sulindac sulfone data in SCoB indicate complete degradation of sulindac to sulindac sulfide. Sulindac data indicate that colonic bacteria lead only to reduction of the sulfoxide group of those drugs, with no oxidative product being detected. SCoB material can be useful as a screening tool in simulating sulforeductase activity in the lower intestine at early stages of drug development process.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kostantini, Christina
  • Κωσταντίνη, Χριστίνα

Subjects

dc:subject × 15

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52861

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kostantini, Christina; Κωσταντίνη, Χριστίνα. Understanding and evaluating the performance of orally administered medicinal products in the upper and in the lower gastrointestinal lumen. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52861